Pharmacological approaches have described a reduction of food intake in response to antagonists of mGluR5 in a baboon model of binge-eating disorder [48] and in mGluR5+/+, but not mGluR5-/- mice [47]. This evidence concerns the gene GRM5 and binge eating disorder.